Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1940 1
1946 5
1947 2
1948 4
1949 16
1950 9
1951 11
1952 10
1953 11
1954 12
1955 4
1956 7
1957 5
1958 9
1959 2
1960 6
1961 7
1962 5
1963 7
1964 10
1965 2
1966 1
1968 2
1969 4
1970 2
1971 3
1972 1
1973 2
1974 2
1975 1
1979 1
1980 4
1981 6
1982 2
1983 1
1984 1
1985 2
1987 1
1988 1
1990 1
1991 1
1992 1
1994 1
1997 1
1998 1
2000 1
2002 1
2004 1
2005 1
2006 2
2008 1
2010 1
2011 4
2012 2
2013 1
2014 3
2015 5
2016 5
2017 2
2018 5
2019 5
2020 7
2021 9
2022 8
2023 4
2024 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

250 results

Results by year

Filters applied: . Clear all
Page 1
Five-Year Outcomes of FOLFIRINOX vs Gemcitabine as Adjuvant Therapy for Pancreatic Cancer: A Randomized Clinical Trial.
Conroy T, Castan F, Lopez A, Turpin A, Ben Abdelghani M, Wei AC, Mitry E, Biagi JJ, Evesque L, Artru P, Lecomte T, Assenat E, Bauguion L, Ychou M, Bouché O, Monard L, Lambert A, Hammel P; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. JAMA Oncol. 2022 Nov 1;8(11):1571-1578. doi: 10.1001/jamaoncol.2022.3829. JAMA Oncol. 2022. PMID: 36048453 Free PMC article. Clinical Trial.
FOLFIRINOX or Gemcitabine as Adjuvant Therapy for Pancreatic Cancer.
Conroy T, Hammel P, Hebbar M, Ben Abdelghani M, Wei AC, Raoul JL, Choné L, Francois E, Artru P, Biagi JJ, Lecomte T, Assenat E, Faroux R, Ychou M, Volet J, Sauvanet A, Breysacher G, Di Fiore F, Cripps C, Kavan P, Texereau P, Bouhier-Leporrier K, Khemissa-Akouz F, Legoux JL, Juzyna B, Gourgou S, O'Callaghan CJ, Jouffroy-Zeller C, Rat P, Malka D, Castan F, Bachet JB; Canadian Cancer Trials Group and the Unicancer-GI–PRODIGE Group. Conroy T, et al. N Engl J Med. 2018 Dec 20;379(25):2395-2406. doi: 10.1056/NEJMoa1809775. N Engl J Med. 2018. PMID: 30575490 Clinical Trial.
Anticoagulation and Bleeding during Veno-Venous Extracorporeal Membrane Oxygenation: Insights from the PROTECMO Study.
Martucci G, Giani M, Schmidt M, Tanaka K, Tabatabai A, Tuzzolino F, Agerstrand C, Riera J, Ramanan R, Grasselli G, Ait Hssain A, Gannon WD, Buabbas S, Gorjup V, Trethowan B, Rizzo M, Fanelli V, Jeon K, De Pascale G, Combes A, Ranieri MV, Duburcq T, Foti G, Chico JI, Balik M, Broman LM, Schellongowski P, Buscher H, Lorusso R, Brodie D, Arcadipane A; International ECMO Network (ECMONet). Martucci G, et al. Am J Respir Crit Care Med. 2024 Feb 15;209(4):417-426. doi: 10.1164/rccm.202305-0896OC. Am J Respir Crit Care Med. 2024. PMID: 37943110
Transfusion practice in patients receiving VV ECMO (PROTECMO): a prospective, multicentre, observational study.
Martucci G, Schmidt M, Agerstrand C, Tabatabai A, Tuzzolino F, Giani M, Ramanan R, Grasselli G, Schellongowski P, Riera J, Hssain AA, Duburcq T, Gorjup V, De Pascale G, Buabbas S, Gannon WD, Jeon K, Trethowan B, Fanelli V, Chico JI, Balik M, Broman LM, Pesenti A, Combes A, Ranieri MV, Foti G, Buscher H, Tanaka K, Lorusso R, Arcadipane A, Brodie D; International ECMO Network (ECMONet). Martucci G, et al. Lancet Respir Med. 2023 Mar;11(3):245-255. doi: 10.1016/S2213-2600(22)00353-8. Epub 2022 Oct 11. Lancet Respir Med. 2023. PMID: 36240836
[Male polyarthritis].
FORESTIER J, JACQUELINE F. FORESTIER J, et al. Ann Rheum Dis. 1952 Dec;11(4):264-71. doi: 10.1136/ard.11.4.264. Ann Rheum Dis. 1952. PMID: 13017476 Free PMC article. No abstract available.
Beyond MEN1, When to Think About MEN4? Retrospective Study on 5600 Patients in the French Population and Literature Review.
Chevalier B, Coppin L, Romanet P, Cuny T, Maïza JC, Abeillon J, Forestier J, Walter T, Gilly O, Le Bras M, Smati S, Nunes ML, Geslot A, Grunenwald S, Mouly C, Arnault G, Wagner K, Koumakis E, Cortet-Rudelli C, Merlen É, Jannin A, Espiard S, Morange I, Baudin É, Cavaille M, Tauveron I, Teissier MP, Borson-Chazot F, Mirebeau-Prunier D, Savagner F, Pasmant É, Giraud S, Vantyghem MC, Goudet P, Barlier A, Cardot-Bauters C, Odou MF. Chevalier B, et al. Among authors: forestier j. J Clin Endocrinol Metab. 2024 Jun 17;109(7):e1482-e1493. doi: 10.1210/clinem/dgae055. J Clin Endocrinol Metab. 2024. PMID: 38288531 Review.
Characterization, Prognosis, and Treatment of Patients With Metastatic Lung Carcinoid Tumors.
Robelin P, Hadoux J, Forestier J, Planchard D, Hervieu V, Berdelou A, Scoazec JY, Valette PJ, Leboulleux S, Ducreux M, Lombard-Bohas C, Baudin E, Walter T. Robelin P, et al. Among authors: forestier j. J Thorac Oncol. 2019 Jun;14(6):993-1002. doi: 10.1016/j.jtho.2019.02.002. Epub 2019 Feb 13. J Thorac Oncol. 2019. PMID: 30771520 Free article. Review.
[Rhizomelic pseudopolyarthritis].
FORESTIER J, CERTONCINY A. FORESTIER J, et al. Reumatismo. 1954 May-Jun;6(3):137-47. Reumatismo. 1954. PMID: 13194934 Italian. No abstract available.
[Rhizomelic pseudo-polarythritis].
FORESTIER J, CERTONCINY A. FORESTIER J, et al. Rev Rhum Mal Osteoartic. 1953 Dec;20(12):854-62. Rev Rhum Mal Osteoartic. 1953. PMID: 13156288 Undetermined Language. No abstract available.
250 results